Immunovant · 10 hours ago
Sr. Director, Market Insights & Analytics
Maximize your interview chances
BiotechnologyPharmaceutical
Insider Connection @Immunovant
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Create insights generation plan(s) that addresses key business questions and delivers deep customer insights across a range of product development and commercialization scenarios
Lead the design, analysis and report out of primary market research for maximum business impact
Cultivate syndicated data sources and supporting analytics
Synthesize data from multiple sources to convey a cohesive, data-driven story and contribute to actionable and measurable recommendations
Collaborate with key cross-functional partners to prioritize strategic recommendations and tactical business initiatives
Manage the supportive market research to optimize both unbranded and branded campaigns
Collaborate with the forecasting team to ensure key insights are incorporated into forecast assumptions
Build measurement plans based on strategic imperatives, communication objectives and marketing strategies
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
BA/BS required; MBA and/or other relevant graduate degree strongly preferred
Minimum 10 years experience in Market Research or other analytical work in the pharmaceutical, biotech or related industries
Previous experience managing primary research projects and analysis, including both qual and quant methodologies
Previous experience managing a team
Excellent oral, written and presentation skills
Experience supporting launch products
Strong cross-functional and interpersonal skills
Ability to effectively manage multiple competing priorities
Preferred
MBA and/or other relevant graduate degree strongly preferred
Benefits
Medical
Dental
Vision
401k
Unlimited paid time off
Parental leave
Company
Immunovant
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Funding
Current Stage
Public CompanyTotal Funding
$864.4MKey Investors
Roivant Sciences
2023-09-27Post Ipo Equity· $450M
2022-10-04Post Ipo Equity· $75M
2021-08-02Post Ipo Equity· $200M
Recent News
GlobeNewswire News Room
2024-11-07
2024-06-05
2024-06-05
Company data provided by crunchbase